Complement C2 receptor inhibitor trispanning: A novel human complement inhibitory receptor

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 356-366

  Inal, Jameel M ^a   Hui, Kwok Min ^a   Miot, Sylvie ^a   Lange, Sigrun ^b   Ramirez, Marcel Ivan ^c   Schneider, Brigitte ^a   Krueger, Gerhard ^d   Schifferli, Jürg A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT C2 RECEPTOR INHIBITOR TRISPANNING; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; COMPLEMENT RECEPTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; COVALENT BOND; CYTOLYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MEMBRANE STRUCTURE; PARASITE; PARASITE TRANSMISSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; TISSUE DISTRIBUTION;

EID: 10844223613     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.356     Document Type: Article

References (52)

1. Hourcade, D., V. M. Holers, and J. P. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381.
2. Morgan, B. P., and S. Meri. 1994, Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15:369.
3. Matsushita, M., S. Thief, J. C. Jensenius, I. Terai, and T. Fujita. 2000. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165:2637.
4. Harpel, P. C., and N. R. Cooper. 1975. Studies on human plasma C1-inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin and trypsin. J. Clin. Invest. 55:593.
5. Skelly, P. J. 2004. Intravascular schistosomes and complement. Trends Parasitol. 20:570.
6. Norris, K. A., B. Bradt, N. R. Cooper, and M. So. 1991. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 147:2240.
7. Joiner, K. A., W. D. da Silva, M. T. Rimoldi, C. H. Hamner, A. Sher, and T. L. Kipnis. 1988. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. J. Biol. Chem. 263:11327.
8. Fatima, M., M. Horta, and E. J. Ramalho-Pinto. 1991. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro. J. Exp. Med. 174:1399.
9. Inal, J. M. 1999. Schistosoma TOR (trispanning orphan receptor), a novel, antigenic surface receptor of the blood-dwelling, Schistosoma parasite. Biochim. Biophys. Acta 1445:283.
10. Inal, J. M., and J. A. Schifferli. 2002. Complement C2 receptor inhibitor trispanning and the β-chain of C4 share a binding site for complement C2. J. Immunol. 168:5213.
11. Inal, J. M., B. Schneider, M. Armanini, and J. A. Schifferli. 2003. A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice. J. Immunol. 170:4310.
12. 125iodine. In Immunological Techniques Made Easy, 1st Ed. O. Cochet, J.-L. Teillaud, and C. Sautès, eds. Wiley, Chichester, p. 226.
13. Coligan, J. E., A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober. 1993. Current Protocols in immunology. Greene & Wiley, New York.
14. Chang, D. H., C. Angelin-Duclos, and K. Calame. 2000. BLIMP-I: trigger for differentiation of myeloid lineage. Nat. Immunol. 1:169.
15. Whaley, K., and J. North. 1997. Haemolytic assays for whole complement activity and individual components. In Complement, A Practical Approach, 1st Ed. A. W. Dodds and R. B. Sim, eds. Oxford Univ. Press, Oxford, p. 24.
16. Miot, S., S. Crespo, and J. A. Schifferli. 2002. Distinct forms of DAF in urine and blood. J. Immunol. Methods 260:43.
17. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 1st Ed. Cold Spring Harbor Lab. Press, New York, p. 1.72.
18. Hu, W., Q. Yan, D. K. Shen, F. Liu, Z. D. Zhu, H. D. Song, X. R. Xu, Z. J. Wang, Y. P. Rong, L. C. Zeng, et al. 2003. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat. Genet. 35:139.
19. Inal, J. M., and R. B. Sim. 2000. A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2. FEBS Lett. 470:131.
20. Oh, K. S., M. H. Kweon, K. H. Rhee, K. H. Lee, and H. C. Sung. 2003. Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues. Immunology 110:73.
21. Oh, K. S., D. K. Na, M. H. Kweon, and H. C. Sung. 2003. Expression and purification of the anticomplementary peptide Sh-CRIT-ed1 (formerly Sh-TOR-ed1) as a tetramultimer in Escherichia coli. Protein Expression Purif. 27:202.
22. Gerard, C., and N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.
23. Imase, A., H. Matsuda, Y. Irie, and Y. Iwamura. 2003. Existence of host DNA sequences in schistosomes-horizontal and vertical transmission. Parasitol. Int. 52:369.
24. Salzet, M., A. Capron, and G. B. Stefano. 2000. Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol. Today 16:536.
25. Subtil, A., M. Delepierre, and A. Dautry-Varsat. 1997. An α-helical signal in the cytosolic domain of the interleukin 2 receptor β chain mediates sorting towards degradation after endocytosis. J. Cell Biol. 136:583.
26. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, et al. 1994. Specific motifs recognized by the SH2 domains of Csk. 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:2777.
27. Li, W., T. Tada, T. Miwa, N. Okada, J. Ito, H. Okada, H. Tateyama, and T. Eimoto. 1999. mRNA expression of complement components and regulators in rat arterial smooth muscle cells. Microbiol. Immunol. 43:585.
28. Ueda, Y., K. Nagasawa, H. Tsukamoto, T. Horiuchi, H. Nishizaka, K. Ikeda, and Y. Niho. 1996. Production of the third and fourth component of complement (C3, C4) by smooth muscle cells. Immunology 89:183.
29. Iborra, A., M. Mayorga, N. Llobet, and P. Martinez. 2003. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. Cell. Immunol. 223:46.
30. Jensen, T. S., L. Bjorge, A. L. Wollen, and M. Ulstein. 1995. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion. Am. J. Reprod. Immunol. 34:1.
31. Bennet, W., A. Bjorkland, B. Sundberg, D. Brandhorst, M. D. Brendel, A. Richards, D. J. White, B. Nilsson, C. G. Groth, and O. Korsgren. 2001. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation 72:312.
32. Pasch, M. C., J. D. Bos, M. R. Daha, and S. S. Asghar. 1999. Transforming growth factor-β isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes. Eur. J. Immunol. 29:100.
33. Moll, S., S. Miot, S. Sadallah, F. Gudat, M. J. Mihatsch, and J. A. Schifferli. 2001. No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int. 59:160.
34. Nangaku, M. 1998. Complement regulatory proteins in glomerular diseases. Kidney Int. 54:1419.
35. Stenbaek, E. I., C. Koch, V. Barkholt, and K. G. Welinder. 1986. Human complement component C2: production and characterization of polyclonal and monoclonal antibodies against C2. Mol. Immunol. 23:879.
36. Laich, A., and R. B. Sim. 2001. Complement C4bC2 complex formation: an investigation by surface plasmon resonance. Biochim. Biophys. Acta 1544:96.
37. Inal, J. M., M. Pascual, P. Lesavre, and J. A. Schifferli. 2003. Complement inhibition in renal diseases. Nephrol. Dial. Transplant. 18:237.
38. Klickstein, L. B., S. F. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7:345.
39. Makrides, S. C., S. M. Scesney, P. J. Ford, K. S. Evans, G. R. Carson, and H. C. Marsh, Jr. 1992. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. J. Biol. Chem. 267:24754.
40. Murray, E. W., and S. M. Robbins. 1998. Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hemolysis cells induces signalling pathways resembling activation by complement. J. Biol. Chem. 273:25279.
41. Hasty, L. A., J. D. Lambris, B. A. Lessey, K. Pruksananonda, and C. R. Lyttle. 1994. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am. J. Obstet. Gynecol. 170:168.
42. Morello, R., and B. Lee. 2002. Insight into podocyte differentiation from the study of human genetic disease: Nail-Patella syndrome and transcriptional regulation in podocytes. Ped. Res. 51:551.
43. Walker, W. H. 2003. Molecular mechanisms controlling Sertoli cell proliferation and differentiation. Endocrinology 144:3719.
44. Eckert, R. L., T. Efimova, S. R. Dashit, S. Balasubramanian, A. Deucher, J. F. Cris, M. Sturniolo, and F. Bone. 2002. Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. J. Invest. Dermatol. Symp. Proc. 7:36.
45. Squier, C. A., and M. J. Kremer. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:7.
46. Morgan, B. P., and C. L. Harris. 2003. Complement therapeutics; history and current progress. Mol. Immunol. 40:159.
47. Moxham, C. P., and C. C. Malbon. 1985. Fat cell β1-adrenergic receptor: structural evidence for existence of disulfide bridges essential for ligand binding. Biochemistry 24:6072.
48. Silva, C. M., and J. A. Cidlowski. 1989. Direct evidence for intra- and intermolecular disulfide bond formation in the human glucocorticoid receptor. J. Biol. Chem. 264:6638.
49. Liu, Y., X. Hong, J. Kappler, L. Jiang, R. Zhang, L. Xu, C. H. Pan, W. E. Martin, R. C. Murphy, H. B. Shu, et al. 2003. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 423:49.
50. Liu, D., and M.-S. Sy. 1997. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J. Immunol. 159:2702.
51. Macaulay, S., M. Polites, D. R. Hewish, and C. W. Ward. 1994. Cysteine-524 is not the only residue involved in the formation of disulfide-bonded dimers of the insulin receptor. Biochem. J. 303:575.
52. Rios, C. D., B. A. Jordan, I. Gomes, and L. A. Devi. 2001. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther. 92:71.